AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

Metastatic prostate cancer is the most common cancer in males and the fifth cause of cancer mortality worldwide. Despite the major progress in this field, leading to the approval of novel anti-androgens, the prognosis is still poor. A significant number of patients acquire an androgen receptor splic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobhani, Navid, Neeli, Praveen Kumar, D’Angelo, Alberto, Pittacolo, Matteo, Sirico, Marianna, Galli, Ilaria Camilla, Roviello, Giandomenico, Nesi, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197232/
https://www.ncbi.nlm.nih.gov/pubmed/34073713
http://dx.doi.org/10.3390/ijms22115515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197232/
https://www.ncbi.nlm.nih.gov/pubmed/34073713
http://dx.doi.org/10.3390/ijms22115515

Ejemplares similares